R. Romeo

Sahlgrenska University Hospital — Sweden

Medicine · Health Sciences

21h-index3.5kcitations95works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis C virus research(52), Liver Disease Diagnosis and Treatment(50), Hepatitis B Virus Studies(42), Hepatocellular Carcinoma Treatment and Prognosis(19), Systemic Lupus Erythematosus Research(8)

Publications95 total

OC-08Rare ATG7 genetic variants predispose to severe fatty liver disease
Digestive and Liver Disease·2021
Hepatitis delta virus and hepatocellular carcinoma: an update
Epidemiology and Infection·2018· 48 citedOpen Access
Molecular cross-talk between the hepatitis C virus and its microenvironment in liver fibrogenesis.
The Open Virology Journal·2017Open Access
Chronic Hepatitis Delta Virus (HDV) infection: What do we need to know?
Journal of Liver·2016
Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenib
United European Gastroenterology Journal·2015· 25 citedOpen Access
Hepatitis delta virus: Making the point from virus isolation up to 2014
World Journal of Hepatology·2015· 20 citedOpen Access
High Serum Levels of HDV RNA Are Predictors of Cirrhosis and Liver Cancer in Patients with Chronic Hepatitis Delta
PLoS ONE·2014· 93 citedOpen Access
Hepatitis Delta: Natural history and outcome
Clinical Liver Disease·2013· 4 citedOpen Access
425 IL28B GENOTYPE IN HDV CHRONIC PATIENTS CORRELATES WITH UNFAVOURABLE OUTCOME BUT NOT WITH RESPONSE TO IFN TREATMENT
Journal of Hepatology·2013· 1 citedOpen Access
426 SERUM LEVELS OF HBsAg AND HBVDNA ARE NOT ASSOCIATED TO CLINICAL OUTCOME IN PATIENTS WITH CHRONIC HDV INFECTION
Journal of Hepatology·2013
259 DETERMINANTS OF BLEEDING FROM ESOPHAGEAL VARICES IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB
Journal of Hepatology·2013Open Access
Proteoglycans Act as Cellular Hepatitis Delta Virus Attachment Receptors
PLoS ONE·2013· 70 citedOpen Access
F-36 Transarterial chemoembolization with drug-eluting beads (DEB TACE) for BCLC-A hepatocellular carcinoma (HCC): a radical option?
Digestive and Liver Disease·2013
T-46 Determinants of bleeding from esophageal varices in patients with advanced hepatocellular carcinoma treated with sorafenib
Digestive and Liver Disease·2013
F-12 IL28B genotype in patients with chronic hepatitis delta (HDV) correlates with unfavourable outcome but not with response to IFN treatment
Digestive and Liver Disease·2013Open Access
OC-31 The outcome of chronic hepatitis D is predicted by the levels of HDV viremia
Digestive and Liver Disease·2013Open Access
Gli indicatori biologici di dose ed effetto nella diagnostica delle patologie asbesto-correlate e nella sorveglianza sanitaria degli ex-esposti. [Dose and effect biomarkers in the diagnosis of asbestos-related diseases and health surveillance of exposed workers]
2012· 1 cited
Treatment of Chronic Hepatitis Delta: Mission Impossible?
Gastroenterology·2011· 6 cited
388 DIFFERENT LEVELS OF HDV-RNA AND HBV-DNA AND DIFFERENT EXPRESSION OF HBSAG ARE ASSOCIATED TO DIFFERENT OUTCOMES IN CHRONIC HDV INFECTION
Journal of Hepatology·2011Open Access
Comparison of field practice to registration trials of sorafenib in advanced HCC for effectiveness and tolerability.
Journal of Clinical Oncology·2010
page 1 of 5Next →

Frequent Co-authors

Angelo Sangiovanni(12), Maria Grazia Rumi(11), E. Del Ninno(10), Massimo Colombo(9), Massimo Iavarone(7), Stanislas Pol(6), Valérie Thiers(6), Massimo Colombo(6), Pierangelo Fasani(5), M. Colombo(5), Guido Ronchi(4), M.A. Manini(4), Massimo Colombo(4), Françoise Carnot(4), R. Soffredini(4), M. Colombo(4), P. Berthelot(4), Alberto Morabito(3), Laura Forzenigo(3), G. Ronchi(3)